ConductScience.org, home

Paper9689101

An immune cell-selective interleukin 4 agonist.

Shanafelt AB and 6 others. Proc Natl Acad Sci U S A, 1998. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. An immune cell-selective interleukin 4 agonist. Papers, record 9689101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9689101

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An immune cell-selective interleukin 4 agonist.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2019-05-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shanafelt ABA B
2Forte CPC P
3Kasper JJJ J
4Sanchez-Pescador LL
5Wetzel MM
6Gundel RR
7Greve JMJ M

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-4Major topic
B-Lymphocytes
Binding, Competitive
Cells, Cultured
Endothelium, Vascular
Humans
Receptors, Interleukin-4
T-Lymphocytes

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18616884Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.Cell1996https://conductscience.org/library/papers/8616884PubMed
28616883Insulin-dependent diabetes mellitus.Cell1996https://conductscience.org/library/papers/8616883PubMed
38698849IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.J Clin Invest1996https://conductscience.org/library/papers/8698849PubMed
48893001Functional diversity of helper T lymphocytes.Nature1996https://conductscience.org/library/papers/8893001PubMed
58910586cDNA cloning and characterization of the human interleukin 13 receptor alpha chain.J Biol Chem1996https://conductscience.org/library/papers/8910586PubMed
68991384IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease.Immunol Today1996https://conductscience.org/library/papers/8991384PubMed
78982776Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor.Int Immunol1996https://conductscience.org/library/papers/8982776PubMed
89034722Functions of IL-4 and control of its expression.Crit Rev Immunol1997https://conductscience.org/library/papers/9034722PubMed
99050834A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9050834PubMed
109199969IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins.Int Immunol1997https://conductscience.org/library/papers/9199969PubMed
119299458Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.Biochem Biophys Res Commun1997https://conductscience.org/library/papers/9299458PubMed
126304457LIGAND: a computerized analysis of ligand binding data.Methods Enzymol1983https://conductscience.org/library/papers/6304457PubMed
132419430Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.J Immunol1986https://conductscience.org/library/papers/2419430PubMed
143323813Rapid and efficient site-specific mutagenesis without phenotypic selection.Methods Enzymol1987https://conductscience.org/library/papers/3323813PubMed
151702807
Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
J Immunol1991https://conductscience.org/library/papers/1702807PubMed
161542854Acute gastric mucosal injury associated with the systemic administration of interleukin-4.Surgery1992https://conductscience.org/library/papers/1542854PubMed
171377515Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells.Cytokine1992https://conductscience.org/library/papers/1377515PubMed
181387082Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement.EMBO J1992https://conductscience.org/library/papers/1387082PubMed
191383333Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration.J Immunol1992https://conductscience.org/library/papers/1383333PubMed
201403061Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy.J Clin Oncol1992https://conductscience.org/library/papers/1403061PubMed

See all 35 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
37483220Design of Glycoengineered IL-4 Antagonists Employing Chemical and Biosynthetic Glycosylation.ACS Omega2023https://conductscience.org/library/papers/37483220PubMed
30341437Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis.Nat Rev Rheumatol2019https://conductscience.org/library/papers/30341437PubMed
30319612Mapping Determinants of Cytokine Signaling via Protein Engineering.Front Immunol2018https://conductscience.org/library/papers/30319612PubMed
25493332Insights into cytokine-receptor interactions from cytokine engineering.Annu Rev Immunol2015https://conductscience.org/library/papers/25493332PubMed
23183579Immunology: Evolving superkines for selectivity.Nat Chem Biol2012https://conductscience.org/library/papers/23183579PubMed
20562098Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.J Biol Chem2010https://conductscience.org/library/papers/20562098PubMed
16640778A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.BMC Biol2006https://conductscience.org/library/papers/16640778PubMed
16566861Cytokine and anti-cytokine therapy for asthma.Curr Allergy Asthma Rep2006https://conductscience.org/library/papers/16566861PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL13RA13597PubTator's text mininghttps://conductscience.org/library/genes/3597NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
IL4R3566PubTator's text mininghttps://conductscience.org/library/genes/3566NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9689101

GET https://conductscience.org/api/papers/v1/9689101/references?page=2